Cargando…
Is Interleukin-6 blockade a viable strategy to prevent progression of acute respiratory distress syndrome in non-COVID viral pneumonia?
Autores principales: | Padappayil, Rana Prathap, Yarrarapu, Siva Naga S., Tiperneni, Raghu, Li, Boning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912812/ https://www.ncbi.nlm.nih.gov/pubmed/38014402 http://dx.doi.org/10.1016/j.clicom.2023.02.004 |
Ejemplares similares
-
PULMONARY ALVEOLAR PROTEINOSIS IN THE TIME OF COVID-19: THE RADIOLOGIC MIMICKER
por: TIPERNENI, RAGHU, et al.
Publicado: (2022) -
Blood Being Tricky: Anticoagulation-Resistant Venous Thromboembolism (VTE)
por: Tiperneni, Raghu, et al.
Publicado: (2022) -
Diabetic Ketoacidosis and Hypertriglyceridemiainduced Pancreatitis: Can the Perfect Storm Happen Twice?
por: Tiperneni, Raghu, et al.
Publicado: (2022) -
COVID-19: Prolonged Social Distancing Implementation Strategy Using Blockchain-Based Movement Passes
por: Garg, Chandan, et al.
Publicado: (2020) -
EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
por: ROY, ARCHANA, et al.
Publicado: (2021)